Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diamandis

Showing results (171-180 of 1,134) with videos related to

Pageof 114
Sort By:
The Urologic Clinics of North America|May 1, 1997
Nonprostatic sources of prostate-specific antigenE P Diamandis, H Yu
Clinical Chemistry and Laboratory Medicine|September 25, 2015
Theranos phenomenon - part 2Michelle Li, Eleftherios P Diamandis
Clinical Biochemistry|January 20, 2020
P4 medicine or O4 medicine? The perils of population wide, asymptomatic disease screeningClare Fiala, Eleftherios P Diamandis
BMC Medicine|August 18, 2017
Circulating tumor DNA for personalized lung cancer monitoringClare Fiala, Eleftherios P Diamandis
F1000Research|March 24, 2018
Hubris and SciencesEleftherios P Diamandis, Nick Bouras
F1000Research|January 16, 2018
Can circulating tumor DNA be used for direct and early stage cancer detection?Eleftherios P Diamandis, Clare Fiala
Clinical Chemistry and Laboratory Medicine|March 12, 2020
Circulating tumor DNA (ctDNA) is not a good proxy for liquid biopsies of tumor tissues for early detectionClare Fiala, Eleftherios P Diamandis
BMC Medicine|October 29, 2020
Mutations in normal tissues-some diagnostic and clinical implicationsClare Fiala, Eleftherios P Diamandis
Clinical Biochemistry|April 3, 2018
Benign and malignant scientific irreproducibilityClare Fiala, Eleftherios P Diamandis
Journal of Chromatography|April 8, 1988
Selective determination of urinary free cortisol by liquid chromatography after solid-state extractionE P Diamandis, M D'Costa
Pageof 114

Showing results (171-180 of 1,134) with videos related to

Sort By:
Pageof 114
The Urologic Clinics of North America|May 1, 1997
Nonprostatic sources of prostate-specific antigenE P Diamandis, H Yu
Clinical Chemistry and Laboratory Medicine|September 25, 2015
Theranos phenomenon - part 2Michelle Li, Eleftherios P Diamandis
Clinical Biochemistry|January 20, 2020
P4 medicine or O4 medicine? The perils of population wide, asymptomatic disease screeningClare Fiala, Eleftherios P Diamandis
BMC Medicine|August 18, 2017
Circulating tumor DNA for personalized lung cancer monitoringClare Fiala, Eleftherios P Diamandis
F1000Research|March 24, 2018
Hubris and SciencesEleftherios P Diamandis, Nick Bouras
F1000Research|January 16, 2018
Can circulating tumor DNA be used for direct and early stage cancer detection?Eleftherios P Diamandis, Clare Fiala
Clinical Chemistry and Laboratory Medicine|March 12, 2020
Circulating tumor DNA (ctDNA) is not a good proxy for liquid biopsies of tumor tissues for early detectionClare Fiala, Eleftherios P Diamandis
BMC Medicine|October 29, 2020
Mutations in normal tissues-some diagnostic and clinical implicationsClare Fiala, Eleftherios P Diamandis
Clinical Biochemistry|April 3, 2018
Benign and malignant scientific irreproducibilityClare Fiala, Eleftherios P Diamandis
Journal of Chromatography|April 8, 1988
Selective determination of urinary free cortisol by liquid chromatography after solid-state extractionE P Diamandis, M D'Costa
Pageof 114